Sigilon Therapeutics prices upsized IPO at $18

Sigilon Therapeutics (SGTX) has priced its upsized IPO of 7M common shares (from 5.6M) at $18.00/share, for expected gross proceeds of $126M.
Underwriters' over-allotment is an additional 1.05M shares. Trading kicks off December 4.